Mai, X., Wang, L., Tu, J., Li, J., Li, J., Zhan, Y., . . . Qi, C. (2025). A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis. KeAi Communications Co., Ltd.
Chicago Style (17th ed.) CitationMai, Xiaobin, et al. A Novel Oridonin Analogue, CYD0682, Suppresses Breast Cancer Growth, Angiogenesis, and Metastasis by Inhibiting the ANGPTL4/MAPK Signaling Axis. KeAi Communications Co., Ltd, 2025.
MLA (9th ed.) CitationMai, Xiaobin, et al. A Novel Oridonin Analogue, CYD0682, Suppresses Breast Cancer Growth, Angiogenesis, and Metastasis by Inhibiting the ANGPTL4/MAPK Signaling Axis. KeAi Communications Co., Ltd, 2025.
Warning: These citations may not always be 100% accurate.